Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. - Wikidata - wikimedia - TriplyDB

Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

http://www.wikidata.org/entity/Q34245323

about

Metabolic, autophagic, and mitophagic activities in cancer initiation and progression The dual role of iNOS in cancer Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?Macrophage-tumor cell interactions regulate the function of nitric oxide S-nitrosylation of Ras in breast cancer Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells Signaling and stress: The redox landscape in NOS2 biology Melanoma NOS1 expression promotes dysfunctional IFN signaling Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.Household income is associated with the p53 mutation frequency in human breast tumors WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay Identification of mammary epithelial cells subject to chronic oxidative stress in mammary epithelium of young women and teenagers living in USA: implication for breast carcinogenesis.Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.Enhanced resting-state dynamics of the hemoglobin signal as a novel biomarker for detection of breast cancer.The immunogenetics of Psoriasis: A comprehensive review.S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.Biological signaling by small inorganic molecules Nitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications.Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms

P2860

Q26745503-1488C07F-025C-45A6-AB7F-6C025510A88F Q26786135-F9F12BEF-F55B-43F4-B1F9-3D3D676B72A9 Q26821895-AF0C3A65-1B78-494D-9016-451F0605FA14 Q27010373-B60E2B33-A4E5-44FA-9307-75318536F3B9 Q28384490-49087886-1BD5-41DC-8D80-C4F5A7229C94 Q28387657-1C7C45D5-C0D9-481A-AB1F-DDED18D1C32A Q28483470-AE4FE8A9-1124-4B0F-B3E8-2268BD19628D Q28550726-9D8B9454-97FF-46F9-98B8-A4A95245A716 Q28833738-B53910D9-4386-454A-82E0-D838FB8AA1F3 Q30413226-0C60E6B0-1A5E-4AF4-A641-B0E061A2153B Q33674627-CEEB52DD-FA46-4E79-AAE3-036F35729813 Q33739233-F411C208-121D-42B0-B4DC-F08ACEB35E45 Q33772144-9B544120-04C0-4FFE-A895-6F0963E63F33 Q33789920-49C7F39D-B737-4F8A-A52B-1A41957A9037 Q34305047-8C2AD3A8-E2ED-4980-B1C1-2A833B722E64 Q34452128-42F2FC99-452D-4F94-BA84-06375AA351D6 Q34593813-B74D8269-90E0-41BF-895A-314C63FB46B2 Q34613059-BBE77571-EAF0-413B-8F08-6BCD0C9E07CD Q34618790-BC9D16D0-241C-4FE7-89D8-C79B4F4AB0B2 Q34851241-FACB415E-D39C-4DC7-859F-8EEB1930F344 Q35144499-D45DD472-48DE-4536-9398-0DC817493070 Q35258324-7A79CCE5-3323-4CD6-B033-EA250CD4CC5D Q35638851-747AD727-8478-4789-98DF-8D3D3C237FA4 Q35701943-F9B7081E-0A34-427C-9AE2-03DA6D9AE6F2 Q35718310-12C91247-5412-436D-8DE6-55AC75E377C3 Q35742389-A8DCFE46-AA9D-4EF3-B941-E508B7081048 Q35842150-FFBB528B-8679-4A95-A520-37B6A117C996 Q35850187-41B8D6A9-6E51-4882-BDD0-0B57FEAA05B2 Q35862690-D9FC38D8-BEC2-4FD7-A730-681E7E240672 Q35911651-1E65C92A-103E-4666-8094-042369527F36 Q36050039-EA231ACC-E673-4F95-AE2E-B765E76AA213 Q36090325-7F04C9F9-B8C0-43BA-A62C-F7DDF2620132 Q36171590-B1C101D0-57B7-4F6C-B400-F2034E9D38A6 Q36236780-DFDAD1CB-47ED-4E76-8F1D-1A459D493289 Q36294465-24A23F03-AC25-4534-A0D8-DE3DAD87A58C Q36369201-66AFAB72-92E1-4EDD-A88C-DBB5FC98E776 Q36376440-83BA337F-66E9-458B-BCC2-C3871361871A Q36378173-6CF83B35-9A5F-402D-B48E-EA2B870CAEF0 Q36476273-A0D9E45B-D086-4A7D-823B-5226E052F14A Q36500327-B2BE2EFB-C3C7-4A9F-8E93-C11277274AA8

P2860

Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

http://www.wikidata.org/entity/Q34245323

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@ast

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@en

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@nl

type

label

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@ast

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@en

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@nl

prefLabel

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@ast

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@en

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@nl

P1433

Q34245323-4B9B440C-4CD3-45AD-B26D-46C76F903A30

P1476

Q34245323-1181DD52-B4C4-44A6-9E8B-F55927664619

P2093

Q34245323-06490349-7892-4C0E-AA3E-919CB9EC30AB

Q34245323-11D4E005-304D-4A6C-96C9-3B41C1FD4DEA

Q34245323-18E744F2-691C-4B0B-AF56-5CFDF382F2FC

Q34245323-2B13B571-3F27-42FC-8223-FC69A5D2090E

Q34245323-4046AA49-3DBC-44EB-BC04-43AE65986843

Q34245323-431955D8-047F-4134-9A36-48D8F331ED7C

Q34245323-5BAACF6B-54E1-40C5-AFEC-87E2ED37A1B1

Q34245323-5E7F9873-78F7-4E65-94BD-208FB97B3533

Q34245323-6A00E4B1-082F-4231-848E-AC8594DD7182

Q34245323-ABA27FD0-D0C6-4B01-AF62-3230CAB7432D

P2860

Q34245323-017F6F75-C906-43F9-ABFB-6740CD34E62C

Q34245323-01D86658-5E3A-45D2-B4BC-018F7E4F1968

Q34245323-074A3E27-4A01-4392-A023-F35FDDFAF366

Q34245323-14A378B1-27A3-4187-AA03-4D7144832CB1

Q34245323-18827FC2-86F1-4FD5-8263-9BB9D84F3C84

Q34245323-18D94F45-4B48-4C63-A83A-FCEEC20B89DA

Q34245323-1AEA3752-64DC-44A9-8A29-069021309C03

Q34245323-1BE49C30-5DEE-4F07-A50D-FC8C3146CAFD

Q34245323-1E3E6BC7-E750-4C1A-A042-52F7D25D5733

Q34245323-2542BDC6-24B6-4C3E-8A2A-CD902BA69F65

P304

Q34245323-BBD17803-1CF3-430E-9082-A66B3608DEC1

P31

Q34245323-16F36161-131D-41C3-881B-1B11127889F5

P356

Q34245323-B1D5232F-5A9C-4E5D-98EE-E65A0A230996

P407

Q34245323-066A9D5F-5038-4222-A66E-3AA041BD4C84

P433

Q34245323-D78BD122-037D-4DA1-B672-083865F47A19

P478

Q34245323-303BF010-E55E-41FE-8A2A-3D27FDDEE432

P577

Q34245323-045C7403-BCEC-4F7E-8481-4F213286E880

P5875

Q34245323-ECD1350C-292D-4FD4-B488-EB4FD1CE514D

P698

Q34245323-BF154BD6-FDEE-4F60-A28F-4F0394C5A1CB

P921

Q34245323-2EA080DD-E319-4A86-B377-C9BA04206412

P932

Q34245323-C73B596F-DC86-44AB-ABDB-E8BF93B06C41

P356

P1433

Journal of Clinical Investigation

P1476

Increased NOS2 predicts poor s ...... gative breast cancer patients.

@en

P2093

Brenda J Boersma

http://www.w3.org/2001/XMLSchema#string

Christopher H Switzer

http://www.w3.org/2001/XMLSchema#string

Damali N Martin

http://www.w3.org/2001/XMLSchema#string

David A Wink

http://www.w3.org/2001/XMLSchema#string

Dong H Lee

http://www.w3.org/2001/XMLSchema#string

Harris G Yfantis

http://www.w3.org/2001/XMLSchema#string

Lisa A Ridnour

http://www.w3.org/2001/XMLSchema#string

Ming Yi

http://www.w3.org/2001/XMLSchema#string

Robert M Stephens

http://www.w3.org/2001/XMLSchema#string

Robert S Hudson

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

Bioconductor: open software development for computational biology and bioinformatics

Inflammation and cancer

Statistical significance for genomewide studies

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Effects of estrogen on global gene expression: identification of novel targets of estrogen action

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

P304

3843-3854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI42059

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47556192

http://www.w3.org/2001/XMLSchema#string

P698

20978357

http://www.w3.org/2001/XMLSchema#string

P921

estrogen-receptor negative breast cancer

P932

2964971

http://www.w3.org/2001/XMLSchema#string